Baze nabs $6 mln Series A
Baze, a provider of a blood-based, at home nutritional testing kit, has raised $6 million in Series A funding. Nature's Way was the lead investor.
13 August 2019•4 mins read
Baze, a provider of a blood-based, at home nutritional testing kit, has raised $6 million in Series A funding. Nature's Way was the lead investor.
